(Health-NewsWire.Net, November 15, 2018 ) The "Global Drug Discovery Informatics Market Analysis to 2025" is a specialized and in-depth study of the drug discovery informatics industry with a focus on the global market trend. The report aims to provide an overview of global drug discovery informatics market with detailed market segmentation by product, usage, function, and end user. The global drug discovery informatics market is expected to witness substantial growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
Some of the key players influencing the market are PerkinElmer, Inc., Schrödinger, LLC, Certara, L.P., Infosys Limited, IBM, Collaborative Drug Discovery, Inc., Jubilant Life Sciences Ltd., Thermo Fisher Scientific Inc., Charles River, and Novo Informatics Pvt. Ltd. among others.
Request sample copy @ http://bit.ly/2yoqbrn
Drug Discovery Informatics enables the users to address large volume of data storage & management and processing & analyzing the obtained results. These drug discovery informatics platforms utilize bioinformatics algorithms for processing life science data and uses various in silico models for analyzing the data obtained.
Large volume of data procured by innovative methods and the need for an efficient tool to analyze this data are anticipated to drive the market of drug discovery informatics in the coming years. In recent years, various collaborations have been seen amongst the drug discovery informatics providers, which proves to be a major opportunity in the market.
Based on product, the market is segmented as service and software. The software segment was further classified as discovery informatics and development informatics. The drug discovery informatics market based on the usage is segmented as, in house informatics and outsourced informatics. The market has been classified by the function, such as, libraries & database preparations, molecular modelling, docking, lead generation informatics, and other functions. Based on end users, the market is segmented as contract research organizations, pharmaceutical & biotechnological companies, and other end users.
The market of drug discovery informatics is anticipated to witness rapid growth in the region of North America in the upcoming years. Various technological advancements and increasing awareness regarding the application of informatics for drug discovery is considered to be major factors fuelling the growth of the market. During the forecast period, Asia Pacific is expected to offer wide growth opportunities for the growth of drug discovery informatics market.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
Inquire Before Buying @ http://bit.ly/2yoqaUl
The report also includes the profiles of key drug discovery informatics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last three years, key development in past three years.
The Insight Partners